secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vicarious Surgical Inc. (RBOT)
CIK:        0001812173
Form:       8-K
Filed at:   2022-08-08T23:59:59+00:00
Accession:  0001213900-22-045420
Event type: earnings
Sentiment:  negative
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vicarious Surgical Q2 2022: adjusted net loss $19.1M, operating expenses up 189% YoY
--------------------------------------------------------------------------------

- Operating expenses of $19.1M for Q2 2022, up from $6.6M in Q2 2021; R&D $10.1M, G&A $7.8M, S&M $1.3M.
- Adjusted net loss of $19.1M ($0.16 loss per share) vs $6.6M ($0.08 loss per share) prior year.
- GAAP net loss of $1.5M ($0.01 loss per share) vs $6.6M ($0.08 loss per share) prior year.
- Cash burn rate for Q2 2022 was $15.7M; no revenue reported (pre-commercial stage).
- Beta 2 system development ongoing; announced Center of Excellence partnerships with UH Ventures and HCA Healthcare.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812173/000121390022045420/0001213900-22-045420-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812173/000121390022045420/ea163898-8k_vicarious.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-045420

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer